TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10942978

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 8621137

Group type: EXPERIMENTAL
Intervention: Ultrasonography with Trucut needle
Number of subjects: 836

Group type: EXPERIMENTAL
Intervention: Ultrasonography with automatic biopsy needle
Number of subjects: 836

Group type: COMPARATOR
Intervention: Trucut needle without ultrasonography
Number of subjects: 836

Group type: COMPARATOR
Intervention: Automatic biopsy needle without ultrasonography
Number of subjects: 836

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 836

Group type: EXPERIMENTAL
Intervention: Automatic biopsy needle
Number of subjects: 836

Group type: COMPARATOR
Intervention: Trucut needle
Number of subjects: 836
Study: 1727581

Group type: EXPERIMENTAL
Intervention: Intrauterine PGF2 alpha infusion (20 mg diluted in 500 mL NaCl 0.9%)
Number of subjects: 22

Group type: COMPARATOR
Intervention: IV oxytocin infusion (increasing doses)
Number of subjects: 22
Study: 6690963

Group type: EXPERIMENTAL
Intervention: Gastroplasty plus diet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 60
Study: 31133472

Group type: EXPERIMENTAL
Intervention: Visit-to-visit systolic BP variability
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Visit-to-visit diastolic BP variability
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Visit-to-visit pulse pressure variability
Number of subjects: 122
Study: 26890999

Group type: EXPERIMENTAL
Intervention: Adolescent Coping With Depression Course and Functional Family Therapy for SUD (depression treatment followed by SUD treatment)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Adolescent Coping With Depression Course and Functional Family Therapy for SUD (SUD treatment followed by depression treatment)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Adolescent Coping With Depression Course and Functional Family Therapy for SUD (coordinated treatment)
Number of subjects: 170
Study: 26412509

Group type: EXPERIMENTAL
Intervention: Memory Box (personalized multimedia device)
Number of subjects: 11
Study: 24757032

Group type: EXPERIMENTAL
Intervention: 2 physiotherapy booster sessions (30 minutes each)
Number of subjects: 78

Group type: COMPARATOR
Intervention: No booster sessions (control)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Booster group
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 23019948

Group type: EXPERIMENTAL
Intervention: Relaxing manipulation and joint regulation (Group 2)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Relaxing manipulation (Group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Relaxing manipulation (normal group)
Number of subjects: 20
Study: 20404423

Group type: EXPERIMENTAL
Intervention: Allopurinol (100 mg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17692615

Group type: EXPERIMENTAL
Intervention: Fenoldopam (0.1 mg*kg‐1*min‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dopamine (3 mg*kg‐1*min‐1)
Number of subjects: 40
Study: 15582638

Group type: EXPERIMENTAL
Intervention: Turning every 4 h on a viscoelastic foam (VE) mattress (n = 67)
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Turning every 2 h on a standard institutional (SI) mattress (n = 65)
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Turning every 3 h on a SI mattress (n = 65)
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Turning every 6 h on a VE mattress (n = 65)
Number of subjects: 838

Group type: COMPARATOR
Intervention: Standard preventive care (n = 576)
Number of subjects: 838
Study: 11933553

Group type: EXPERIMENTAL
Intervention: Bi-ventricular pacing mode
Number of subjects: 67

Group type: COMPARATOR
Intervention: Inactive mode
Number of subjects: 67
Study: 9785761

Group type: EXPERIMENTAL
Intervention: Exercise group (15 women) - daily outdoor walking and gymnastic training for 12 months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (20 women) - treated with calcium lactate and 1 alpha-hydroxyvitamin D3
Number of subjects: 35
Study: 7710397

Group type: EXPERIMENTAL
Intervention: Acute-phase ROP status between 32 and 42 weeks postconceptional age
Number of subjects: 4099

Group type: EXPERIMENTAL
Intervention: Cicatricial status at age 1 year
Number of subjects: 4099
Study: 2744910

Group type: EXPERIMENTAL
Intervention: Carbocysteine (4.5 g/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucose (placebo)
Number of subjects: 0
Study: 341635

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 6113175

Group type: EXPERIMENTAL
Intervention: Lormetazepam (Noctamid) 1 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Diazepam (Valium) 5 mg
Number of subjects: 100
Study: 29994244

Group type: EXPERIMENTAL
Intervention: Proposed framework for visual representation and categorization
Number of subjects: 0
Study: 29765200

Group type: EXPERIMENTAL
Intervention: AZD1981 (400 mg BID)
Number of subjects: 1140

Group type: EXPERIMENTAL
Intervention: AZD1981 (other doses)
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1140
Study: 27391857

Group type: EXPERIMENTAL
Intervention: Gynura pseudochina DC. var. hispida Thv. ointment
Number of subjects: 25

Group type: COMPARATOR
Intervention: 0.1% triamcinolone (TA) cream
Number of subjects: 25
Study: 24670946

Group type: EXPERIMENTAL
Intervention: Whey protein and polydextrose (PPX) snack bar
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isoenergetic control snack bar
Number of subjects: 10
Study: 21257799

Group type: EXPERIMENTAL
Intervention: Roflumilast (oral daily doses for 14 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Digoxin (single oral dose on day 1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Roflumilast and digoxin coadministration
Number of subjects: 16
Study: 19171611

Group type: EXPERIMENTAL
Intervention: School-based supervised therapy
Number of subjects: 290

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 290
Study: 17242947

Group type: EXPERIMENTAL
Intervention: Hypoxic absolute trial (HAT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control trial (CT)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hypoxic relative trial (HRT)
Number of subjects: 8
Study: 15969659

Group type: EXPERIMENTAL
Intervention: Aspirin challenge
Number of subjects: 117
Study: 12043875

Group type: EXPERIMENTAL
Intervention: Prefabricated post and core permanently cemented
Number of subjects: 28
Study: 9613305

Group type: EXPERIMENTAL
Intervention: Low-dose regional labour analgesia (bupivacaine and fentanyl)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Spinal anaesthesia for elective Caesarean section
Number of subjects: 60
Study: 7859894

Group type: EXPERIMENTAL
Intervention: Easiest mode of insulin injection
Number of subjects: 743

Group type: COMPARATOR
Intervention: Two different forms of insulin delivery
Number of subjects: 743
Study: 2510498

Group type: EXPERIMENTAL
Intervention: Misoprostol (400 micrograms)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 797259

Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 31337414

Group type: EXPERIMENTAL
Intervention: Two-way texting intervention (daily text messages with follow-up only if desired or if a complication is suspected)
Number of subjects: 722

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 722
Study: 29029606

Group type: EXPERIMENTAL
Intervention: Shared Care
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Dual Care
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Medical Care
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Chiropractic-inclusive models (Shared Care and Dual Care)
Number of subjects: 131
Study: 26143387

Group type: EXPERIMENTAL
Intervention: Group 1 (anxiety score ≤ 25)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Group 2 (anxiety score > 25)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Preprocedure anxiety score > 25
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Male operator
Number of subjects: 109
Study: 24423419

Group type: EXPERIMENTAL
Intervention: Fospropofol (initial dose of 6.5 mg/kg, supplemental doses of 1.6 mg/kg as needed)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam (initial dose of 0.05 mg/kg, supplemental doses of 0.02 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fospropofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fospropofol and Midazolam
Number of subjects: 60
Study: 21412134

Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dexacort, 20 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19414694

Group type: EXPERIMENTAL
Intervention: DPTaP‐Hib vaccine first
Number of subjects: 120

Group type: COMPARATOR
Intervention: PCV first
Number of subjects: 120
Study: 17846346

Group type: EXPERIMENTAL
Intervention: Plasma cardiotrophin-1 in patients with inappropriate left ventricular mass
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Plasma cardiotrophin-1 after 1 year of antihypertensive treatment
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Correlation of plasma cardiotrophin-1 with left ventricular mass
Number of subjects: 118
Study: 15089810

Group type: EXPERIMENTAL
Intervention: Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF)
Number of subjects: 0
Study: 10876462

Group type: EXPERIMENTAL
Intervention: Lidocaine (40 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol (20 mg)
Number of subjects: 30
Study: 9179056

Group type: EXPERIMENTAL
Intervention: High dose chlorambucil (HD-CLB)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)
Number of subjects: 228
Study: 1489115

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (1 mg/kg over 1 h)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Lateral position
Number of subjects: 8
Study: 2951826

Group type: EXPERIMENTAL
Intervention: Combination of ipratropium bromide (40 micrograms) and fenoterol (200 micrograms)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fenoterol (200 micrograms)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40 micrograms)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of ipratropium bromide and fenoterol
Number of subjects: 24
Study: 30112792

Group type: EXPERIMENTAL
Intervention: MYL-1501D
Number of subjects: 560

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 560

Group type: COMPARATOR
Intervention: MYL-1501D and Insulin glargine
Number of subjects: 560
Study: 28231078

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise training (MIET) for 10 weeks (25-40 min/d, 3 d/wk at 50%-70% of heart rate reserve)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise training (MIET) for 10 weeks
Number of subjects: 24
Study: 25779914

Group type: EXPERIMENTAL
Intervention: Neck muscle vibration
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Motor imagery
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Action observation
Number of subjects: 45
Study: 23535971

Group type: EXPERIMENTAL
Intervention: Promotion message
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Prevention message
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nonfit conditions
Number of subjects: 98
Study: 21524790

Group type: COMPARATOR
Intervention: Cercon control (CC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cercon fatigue (CF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lava control (LC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lava fatigue (LF)
Number of subjects: 20
Study: 18065202

Group type: EXPERIMENTAL
Intervention: Soy isoflavone 40 mg once a day for 6 months
Number of subjects: 47

Group type: COMPARATOR
Intervention: Casein placebo 40 mg once a day for 6 months
Number of subjects: 47
Study: 16253974

Group type: EXPERIMENTAL
Intervention: Etonorgestrel
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Levonorgestrel
Number of subjects: 111
Study: 14556479

Group type: EXPERIMENTAL
Intervention: Intensive and short duration chemotherapy (LMB protocols)
Number of subjects: 0
Study: 10229288

Group type: COMPARATOR
Intervention: Depressed group (n = 9)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Non-depressed group (n = 53)
Number of subjects: 62
Study: 9084317

Group type: EXPERIMENTAL
Intervention: Bioresorbable membrane (Guidor USA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (flap surgery alone)
Number of subjects: 8
Study: 1906239

Group type: EXPERIMENTAL
Intervention: TAP-144-SR 3.75 mg administered subcutaneously at 4-week intervals for 12 weeks (total of 3 injections)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Diethylstilbestrol diphosphate 100 mg administered orally three times a day for 12 weeks
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: TAP-144-SR
Number of subjects: 134

Group type: COMPARATOR
Intervention: Diethylstilbestrol diphosphate
Number of subjects: 134
Study: 6125155

Group type: EXPERIMENTAL
Intervention: estazolam (2 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 31802455

Group type: EXPERIMENTAL
Intervention: TimeSlips intervention (one hour, once a week for six weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normal daily activities)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TimeSlips intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 29238169

Group type: EXPERIMENTAL
Intervention: Test formulation of flupirtine maleate capsule under fasting condition
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Test formulation of flupirtine maleate capsule under fed condition
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference formulation of flupirtine maleate capsule under fasting condition
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference formulation of flupirtine maleate capsule under fed condition
Number of subjects: 48
Study: 27798030

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus usual care
Number of subjects: 88

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 88
Study: 24929624

Group type: EXPERIMENTAL
Intervention: sitagliptin 100 mg/day
Number of subjects: 76
Study: 22383949

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC) administered for 60 days followed by placebo for another 60 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21158957

Group type: EXPERIMENTAL
Intervention: Healthy Foods North (HFN) programme; a multi-institutional and culturally appropriate intervention to improve dietary adequacy and reduce chronic disease risk; specific dosage and duration not available.
Number of subjects: 0
Study: 17685739

Group type: EXPERIMENTAL
Intervention: Piracetam (4800 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16351366

Group type: EXPERIMENTAL
Intervention: Deductive identity groups with depersonalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inductive identity groups with depersonalization
Number of subjects: 0
Study: 11909983

Group type: EXPERIMENTAL
Intervention: Dopamine agonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 0
Study: 9607010

Group type: EXPERIMENTAL
Intervention: SPf66
Number of subjects: 630

Group type: COMPARATOR
Intervention: Control vaccine
Number of subjects: 630
Study: 8550252

Group type: EXPERIMENTAL
Intervention: 16 weeks of progressive resistive training
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Single bout of resistive exercise
Number of subjects: 13
Study: 2049711

Group type: EXPERIMENTAL
Intervention: Comprehensive awareness program plus bicycle helmet subsidy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comprehensive awareness program
Number of subjects: 0
Study: 6133104

Group type: EXPERIMENTAL
Intervention: Intervention group (health education promoting a cholesterol-lowering diet, smoking cessation, weight control, physical activity, treatment of arterial hypertension)
Number of subjects: 19409

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 19409
Study: 31248399

Group type: EXPERIMENTAL
Intervention: Educational leaflet
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Oral presentation
Number of subjects: 292

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 292
Study: 30381311

Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg once daily along with conventional management)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional management for FGR
Number of subjects: 140
Study: 25661322

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (25μg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Foley catheter
Number of subjects: 100
Study: 23738741

Group type: EXPERIMENTAL
Intervention: Health message condition
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Social norm message condition
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control message condition
Number of subjects: 129
Study: 21275439

Group type: EXPERIMENTAL
Intervention: Armodafinil 50 mg on day 1, 100 mg on day 2, and 150 mg once daily on days 3 through 7
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 50
Study: 19892047

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous mononuclear bone marrow stem cells (BMSCs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no BMSCs)
Number of subjects: 60
Study: 16500493

Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography
Number of subjects: 24
Study: 15342836

Group type: COMPARATOR
Intervention: Non-sleep-deprived (NSD) EEGs
Number of subjects: 820

Group type: COMPARATOR
Intervention: Partially sleep-deprived (PSD) EEGs
Number of subjects: 820

Group type: COMPARATOR
Intervention: Standard sleep-deprived (SSD) EEGs
Number of subjects: 820
Study: 11032279

Group type: EXPERIMENTAL
Intervention: 5-HT3 receptor antagonists
Number of subjects: 41

Group type: COMPARATOR
Intervention: Traditional antiemetic agents (droperidol)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Traditional antiemetic agents (metoclopramide)
Number of subjects: 41
Study: 9064405

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of drugs (group IM)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (100%)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Diclofenac (74.2%)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Metamizol (60%)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Multiple drugs (60%)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 176
Study: 1338319

Group type: EXPERIMENTAL
Intervention: D-F 15 mg b.d. for 26 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: D-F
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: D-F (after switching from placebo)
Number of subjects: 45
Study: 6707231

Group type: EXPERIMENTAL
Intervention: 60 mg codeine
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 500 mg acetaminophen
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 1000 mg acetaminophen
Number of subjects: 108
Study: 30921187

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standardized medical treatment
Number of subjects: 98
Study: 29129600

Group type: EXPERIMENTAL
Intervention: MABp1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 26794722

Group type: EXPERIMENTAL
Intervention: Invasive strategy (early coronary angiography with immediate assessment for percutaneous coronary intervention, coronary artery bypass graft, and optimum medical treatment)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Conservative strategy (optimum medical treatment alone)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 457

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 457
Study: 24886352

Group type: EXPERIMENTAL
Intervention: Weekly 1.5 hour weight management group until 6 weeks postpartum, combining Slimming World expertise with NHS midwives' clinical advice.
Number of subjects: 570

Group type: COMPARATOR
Intervention: Usual care and two leaflets giving advice on diet and physical activity.
Number of subjects: 570
Study: 23181339

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) intervention, conducted in a home-based setting, for six weeks, twice a week.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo training intervention, conducted in a home-based setting, for six weeks, after a two-week washout period, twice a week.
Number of subjects: 0
Study: 20103032

Group type: EXPERIMENTAL
Intervention: Energy drink (250 mL, sugar-free)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no energy drink)
Number of subjects: 50
Study: 17669707

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fine-needle aspiration (FNA) with measurement of parathyroid hormone (PTH) in the aspirate
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Minimally invasive parathyroidectomy (MIP)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Postoperative follow-up
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fine-needle aspiration (FNA)
Number of subjects: 34
Study: 16284381

Group type: EXPERIMENTAL
Intervention: Difluoromethylornithine (DFMO) plus triamcinolone
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Difluoromethylornithine (DFMO) plus placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Placebo plus triamcinolone
Number of subjects: 124

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 124
Study: 11893781

Group type: EXPERIMENTAL
Intervention: Stick margarine diet (30% of calories as fat)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Soybean oil diet (30% of calories as fat)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Butter diet (30% of calories as fat)
Number of subjects: 19
Study: 10457875

Group type: EXPERIMENTAL
Intervention: Tramadol drops 1.5 mg kg-1 (n = 31)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (normal saline) (n = 29)
Number of subjects: 60